Dietary derived propionate regulates pathogenic fibroblast function and ameliorates experimental arthritis and inflammatory tissue priming

Jasna Friščić, Kerstin Dürholz, Xi Chen, Cecilia Engdahl, Lisa Möller, Georg Schett, Mario M. Zaiss, Markus H. Hoffmann*

*Corresponding author for this work
    9 Citations (Scopus)


    Short-chain fatty acids are gut-bacteria-derived metabolites that execute important regulatory functions on adaptive immune responses, yet their influence on inflammation driven by innate immunity remains understudied. Here, we show that propionate treatment in drinking water or upon local application into the joint reduced experimental arthritis and lowered inflammatory tissue priming mediated by synovial fibroblasts. On a cellular level, incubation of synovial fibroblasts with propionate or a physiological mixture of short-chain fatty acids interfered with production of inflammatory mediators and migration and induced immune-regulatory fibroblast senescence. Our study suggests that propionate mediates its alleviating effect on arthritis by direct abrogation of local arthritogenic fibroblast function.

    Original languageEnglish
    Article number1643
    Issue number5
    Publication statusPublished - 05.2021

    Research Areas and Centers

    • Academic Focus: Center for Infection and Inflammation Research (ZIEL)
    • Centers: Center for Research on Inflammation of the Skin (CRIS)

    Cite this